← Open Payments lookup

CHARLES TILLEY: Open Payments

NPI 1467502286 · LE MARS, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$750 in 52 payments from 10 companies in 2025. Trend: 2023 $567 · 2024 $594 · 2025 $750

Food & beverage: $638Education: $111
CompanyPaymentsAmount
ABBVIE INC.24$192
Teva Pharmaceuticals USA, Inc.6$163
Neurocrine BioSciences, Inc.6$106
Alkermes, Inc.4$79
Janssen Pharmaceuticals, Inc4$67
Otsuka America Pharmaceutical, Inc.4$67
E.R. Squibb & Sons, L.L.C.1$22
Supernus Pharmaceuticals, Inc.1$21
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$20
Takeda Pharmaceuticals U.S.A., Inc.1$14

Products named: VRAYLAR, INGREZZA, ARISTADA, INVEGA SUSTENNA, ABILIFY ASIMTUFII, UZEDY, COBENFY, Qelbree.

Industry payments across IA — which companies pay providers there.